Regenerative technology company StimLabs has enrolled the first patient in a clinical trial using shelf-stable placental tissue to reduce complications following herniated disc surgery.
The multi-center, randomized controlled trial will evaluate the safety and efficacy of Revita, StimLabs’ full-thickness placental allograft, which surgeons will place following lumbar microdiscectomy procedures. Microdiscectomy is a common, minimally invasive procedure to remove the herniated or protruding portion of the intervertebral disc that is compressing the traversing spinal nerve root. Common post-surgical complications include scar tissue formation and reherniation.
The post Can placental tissue implants limit back and leg pain? appeared first on MassDevice.